Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Labcyte  Merged with Deerac Fluidics (2008 )

1190 Borregas Avenue
Sunnyvale, CA 94089
Website Company Summary Management Team

General Management: Keith Love (2007)
Technology: Michael F Miller ; Richard Ellson (2000)
Sales/Marketing: Joseph Olechno
Customer Service: A Mark Bramwell

Outside board: (May no longer be on the board) Elaine Heron (Labcyte Chairman) Joseph D Keegan (ForteBio CEO) Andre Marion (Life Technologies Former CEO) Sandra Panem (Cross Atlantic Capital Partners Partner) Joseph F Smith (Cepheid General Counsel) Jonathan J MacQuitty (Abingworth Management President) Craig C Taylor (Alloy Ventures)
Advisory board: Richard Caprioli (Vanderbilt University Professor) John Comley (PerkinElmer) James B Knight (Dharmacon Sr. Director of Business Development) George McLendon (Duke University Professor)

Business description: Labcyte Inc. uses sound to move liquids. This green technology provides significantly better analytical results while saving money. The ‘touchless’ technology provides dramatically better answers by eliminating pipette tips and the adsorption of compounds during transfer, while saving hundreds of thousands of dollars in decreased consumables. Accuracy is maintained from first drop through last for a wide variety of fluids, including many considered intractable by other techniques. The technology is coupled with our Deerac™ instruments to make Labcyte a leader in liquid handling. Together with the Deerac systems, the award-winning Echo liquid handlers are used in all of the top 10 pharmaceutical companies, as well as in leading academic and research institutions worldwide. Labcyte technologies have broad applications including the fields of compound management, genomics, proteomics, particle manufacturing, encapsulation, imaging mass spectrometry, and live-cell transfer. Labcyte is headquartered in Sunnyvale, California with offices in Dublin, Ireland and has 39 U.S., 7 European and two Japanese patents and additional U.S. and international filings.
Customers include: Bristol-Myers Squibb;  Burnham Institute ;  The Institute of Cancer Research
Partners include: Thermo Fisher Scientific ;  Hosokawa Micron

Rounds: 5
Recent Fundings: Jan 2013   Mar 2008
Capital raised: 57.1M
Last Round: 5.2M
Ownership: Merged with Deerac Fluidics (2008 )

Last Tweets


Last Mentions

Record updated: Jan 2013
Sector: Medical
Year Founded: 2003
Headcount: 26-50 as of Aug 2005
Rounds: 5
Recent Fundings: Jan 2013   Mar 2008
Capital Raised: 57.1M
Last Round: 5.2M
Ownership: Merged with Deerac Fluidics (2008 )